在低喉喉癌的诱导化疗后预测喉食道功能障碍的多组框架

D Mattavelli1, M Compagnoni2, S Calza3

  • 1Unit of Otorhinolaryngology-Head and Neck Surgery, ASST Spedali Civili di Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

ESMO open
|December 30, 2025
PubMed
概括

一个新的PRESERVE模型准确地预测了晚期喉-食道功能障碍和化学疗法响应在晚期喉-鼻支柱状细胞癌患者. 这种基因组和临床模型有助于喉保护策略,以获得更好的患者结果.